0000904454-14-000643.txt : 20140915 0000904454-14-000643.hdr.sgml : 20140915 20140915213740 ACCESSION NUMBER: 0000904454-14-000643 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140911 FILED AS OF DATE: 20140915 DATE AS OF CHANGE: 20140915 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001457612 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-876-8191 MAIL ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC DATE OF NAME CHANGE: 20090304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giannasca Paul CENTRAL INDEX KEY: 0001591874 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36289 FILM NUMBER: 141104399 MAIL ADDRESS: STREET 1: CAMBRIDGE DISCOVERY PARK STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-09-11 0001457612 GENOCEA BIOSCIENCES, INC. GNCA 0001591874 Giannasca Paul C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140 0 1 0 0 VP of Development Common Stock 2014-09-11 4 M 0 4071 2.02 A 4071 D Common Stock 2014-09-11 4 S 0 4071 11.84 D 0 D Stock Option (Right to Buy) 2.02 2014-09-11 4 M 0 4071 0 D 2021-02-16 Common Stock 4071 4259 D The option vests in equal monthly installments over four years beginning on the date of grant (02/17/2011). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/Robert E. Farrell, Jr., Attorney-in-fact 2014-09-15